^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    OncoFOLLOW

    Company:
    OncoDNA
    Type:
    Laboratory Developed Test
    Related tests:

    Details

    Evidence
    News
    OncoFOLLOW is a test based on the analysis of circulating tumor DNA in blood. It is used to monitor the progression of the tumor (burden of the disease) and to detect lack of response or resistance to treatment as soon as it appears. This assay is customised for each patient, as it analyses up to 15 variants previously identified in the tumour of the patient. In addition, it sequences a fixed panel of 40 genes associated with response/resistance to targeted therapies and immunotherapy, and/or frequently mutated in cance
    Cancer:
    Solid Tumor
    Gene:
    CSF1R (Colony stimulating factor 1 receptor), EGFR (Epidermal growth factor receptor), PIK3CB (Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta), RAD50 (RAD50 Double Strand Break Repair Protein), ROS1 (Proto-Oncogene Tyrosine-Protein Kinase ROS), SMO (Smoothened Frizzled Class Receptor)
    See More ...
    Drug:
    Tagrisso (osimertinib), erlotinib
    Method:
    Liquid biopsy